- Global Pharma News & Resources

Migraine Drugs Market To Lead Topline Growth with a Stunning CAGR of 5.2% during 2021-2028 | Key Players Allergan, Merck, Pfizer, Teva, Pfizer, Johnson & Johnson, GlaxoSmithKline, Abbott, Bayer

Migraine Drugs Market Overview –

Migraine is one of the most common neurological diseases that is characterized by recurrent attacks of throbbing head pain. Generally, it is unilateral pain and could last from hours to three days. The pain is often related to increased sensitivity to light, vomiting, nausea, and increased sensitivity to sound. Generally, migraines are more frequent in women as compared to men. The global migraine drugs market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global migraine drugs market is expected to witness significant growth during the forecast period, owing to the increased uptake of novel drug classes.

Request for Sample Copy of Report with Analysis of COVID-19 Impact on Migraine Drugs Market:

Migraine Drugs Market Drivers –

Increasing incidence of migraine cases is expected to drive the growth of the global migraine drugs market during the forecast period. According to the Migraine Research Foundation (MRF), around 18% of women, 6% of men, and 10% of children in the U.S. experience migraines, with around 90% of them having a family history of migraines. According to the same source, migraine is highly common between the ages of 18 and 44 years. Migraine drugs are prescribed by physicians and are used to block pain pathways in the brain. These drugs are administered via pills, nasal sprays, or shots. Thus, these factors are expected to drive the growth of the global migraine drugs market during the forecast period. Furthermore, increased uptake of novel drug classes is expected to boost the global migraine drugs market growth over the forecast period.

Migraine Drugs Market Restraint –

Product recalls by manufacturing companies are expected to hinder the global migraine drugs market growth over the forecast period.

Migraine Drugs Market Regional Insights –

Among regions, Asia Pacific is expected to witness significant growth in the global migraine drugs market during the forecast period. This is owing to increasing public awareness regarding migraine illness among people. Furthermore, North America is expected to register a robust growth rate over the forecast period, presence of key market players such as Pfizer and Abbott Laboratories in the region.

Migraine Drugs Market Competitive Landscape –

Key players operating in the global migraine drugs market are Allergan, Merck, Pfizer, Teva, Pfizer, Johnson & Johnson, Endo International, GlaxoSmithKline, Impax, Abbott, Bayer, Eli Lilly, Ethypharm, Kowa Pharmaceuticals America, Winston Pharmaceuticals, AstraZeneca.

For instance, in December 2019, Allergen USA Inc. received the U.S. Food and Drug Administration (FDA) approval for Ubrelvy tablets indicated for the acute (immediate) treatment of migraine with or without aura in adults.

Inquire To Know More About This Report @

Migraine Drugs Market Segmentation –

Segmentation By Type:

    • Sumatriptan
    • Zolmitriptan
    • Rizatriptan
    • Other Drug

Segmentation By Applications:

    • Hospitals
    • Clinics
    • Household Use
    • Others

Reasons to Purchase this Report:

    • The trendy developments, market shares, and strategies that are employed by means of the essential market players
    • The segment that is anticipated to dominate the market as properly as the segment which holds the highest CAGR in the forecast period
    • Current and future of global Migraine Drugs market outlook in the developed and rising markets
    • Regions/countries that are anticipated to witness the quickest growth rates at some stage in the forecast period

Buy Now This Premium Report to Grow your Business:

Frequently Asked Questions:

    1. What is the scope of the report?
    2. Does this report estimates the current market size?
    3. Does the report provides Market Size in terms of – Value (US$ Mn) and Volume (Thousands of Units) – of the market?
    4. Which segments are covered in this report?
    5. What are the key factors covered in this report?
    6. Does this report offer customization?

About Us:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide.

We strive to offer sapient solutions, expert consultations, and tailored/customized solutions. Our team includes analysts that leverage their years of experience and expertise to create accurate and error-free reports. The domain-specific teams are constantly focused on tracking markets, aiding our clients to gain a competitive edge through high-quality market intelligence. We offer an array of services including, syndicated research, advisory and consulting research process outsourcing, and content management.

Contact Us:

Mr. Shah
Stratagem Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027 / JAPAN +815055391737

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 23-Sep-2021